Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A role for Pms2 in the prevention of tandem CC --> TT substitutions induced by ultraviolet radiation and oxidative stress.

Shin-Darlak CY, Skinner AM, Turker MS.

DNA Repair (Amst). 2005 Jan 2;4(1):51-7.

PMID:
15533837
2.
3.
4.

The frequency of CC to TT tandem mutations in mismatch repair-deficient cells is increased in a cytosine run.

Skinner AM, Dan C, Turker MS.

Mutagenesis. 2008 Mar;23(2):87-91. doi: 10.1093/mutage/gem047. Epub 2008 Jan 4.

PMID:
18178959
5.

High frequency induction of CC to TT tandem mutations in DNA repair-proficient mammalian cells.

Skinner AM, Turker MS.

Photochem Photobiol. 2008 Jan-Feb;84(1):222-7. doi: 10.1111/j.1751-1097.2007.00224.x.

PMID:
18173724
6.

Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.

Shao C, Yin M, Deng L, Stambrook PJ, Doetschman T, Tischfield JA.

Oncogene. 2002 Apr 25;21(18):2840-5.

7.

Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.

Gibson SL, Narayanan L, Hegan DC, Buermeyer AB, Liskay RM, Glazer PM.

Cancer Lett. 2006 Dec 8;244(2):195-202. Epub 2006 Jan 19.

PMID:
16426742
8.

Frequency and types of spontaneous Hprt lymphocyte mutations in Pms2-deficient mice.

Shaddock JG, Dobrovolsky VN, Mittelstaedt RA, Heflich RH, Parsons BL.

Mutat Res. 2006 Mar 20;595(1-2):69-79.

PMID:
16336979
9.

Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency.

Parsons BL, Delongchamp RR, Beland FA, Heflich RH.

Mutagenesis. 2006 Jan;21(1):29-34. Epub 2005 Nov 28.

PMID:
16314341
10.

Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.

Chen PC, Dudley S, Hagen W, Dizon D, Paxton L, Reichow D, Yoon SR, Yang K, Arnheim N, Liskay RM, Lipkin SM.

Cancer Res. 2005 Oct 1;65(19):8662-70.

11.

Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2.

Winter DB, Phung QH, Umar A, Baker SM, Tarone RE, Tanaka K, Liskay RM, Kunkel TA, Bohr VA, Gearhart PJ.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6953-8.

12.

Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres.

Siegl-Cachedenier I, Muñoz P, Flores JM, Klatt P, Blasco MA.

Genes Dev. 2007 Sep 1;21(17):2234-47.

13.

Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q.

Marinovic-Terzic I, Yoshioka-Yamashita A, Shimodaira H, Avdievich E, Hunton IC, Kolodner RD, Edelmann W, Wang JY.

Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13993-8. doi: 10.1073/pnas.0806435105. Epub 2008 Sep 3.

15.

Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: implications for the mechanism of triplet repeat expansion.

Gomes-Pereira M, Fortune MT, Ingram L, McAbney JP, Monckton DG.

Hum Mol Genet. 2004 Aug 15;13(16):1815-25. Epub 2004 Jun 15.

PMID:
15198993
16.

Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.

Mohd AB, Palama B, Nelson SE, Tomer G, Nguyen M, Huo X, Buermeyer AB.

DNA Repair (Amst). 2006 Mar 7;5(3):347-61. Epub 2005 Dec 9.

PMID:
16338176
17.

Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.

Chen Y, Wang J, Fraig MM, Henderson K, Bissada NK, Watson DK, Schweinfest CW.

Int J Oncol. 2003 May;22(5):1033-43.

PMID:
12684669
20.

Supplemental Content

Support Center